AI Verdict
KOPN has stronger fundamentals based on our AI analysis.
KPHMW vs KOPN Fundamental Comparison
| Metric | KPHMW | KOPN |
|---|---|---|
| Revenue | $0.0 | $890,171.0 |
| Net Income | $-10.8M | $-4.2M |
| Net Margin | N/A | -471.8% |
| ROE | -67.2% | -19.7% |
| ROA | -44.7% | -6.9% |
| Current Ratio | 5.99x | 1.47x |
| Debt/Equity | 0.02x | 0.00x |
| EPS | $-2.64 | $-0.03 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KPHMW vs KOPN: Frequently Asked Questions
Is KPHMW or KOPN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KOPN has stronger fundamentals. KPHMW is rated STRONG SELL (78% confidence) while KOPN is rated STRONG SELL (85% confidence). This is not investment advice.
How does KPHMW compare to KOPN fundamentally?
KIORA PHARMACEUTICALS INC has ROE of -67.2% vs KOPIN CORP's -19.7%. Net margins are N/A vs -471.8% respectively.
Which stock pays higher dividends, KPHMW or KOPN?
KPHMW has a dividend yield of N/A or no dividend while KOPN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KPHMW or KOPN for long term?
For long-term investing, consider that KPHMW has STRONG SELL rating with 78% confidence, while KOPN has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KPHMW vs KOPN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KPHMW vs KOPN, the AI consensus favors KOPN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.